Metabolomics aims to measure a chemically diverse metabolome, but the observable metabolome is first defined by extraction. Extraction creates a matrix environment in which metabolites can (1) bind residual proteins, precipitated surfaces, membranes, metals, and other sample components, or (2) serve as substrates for residual catalytic activity. These metabolite-matrix interactions are not fixed; they depend on solvent composition, water content, pH, salt, protein state, and, critically, extraction concentration. As the biomass-to-solvent ratio increases, the concentrations of metabolites, binding sites, and active residual enzymes increase together, raising the opportunity for matrix retention and post-extraction conversion. Consequently, broad metabolome coverage requires treating extraction as an analytical selection step, with solvent conditions, matrix effects, biomass-to-solvent ratio, and extraction linearity controlled, validated, and reported as core determinants of metabolite recovery.
No takes yet. Share an insight, caveat, or question.
Ryan D. Sheldon (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: